Benjamin Goldstein, MD, PhD
Benjamin Goldstein researches bipolar disorder among adolescents. Bipolar disorder is the fourth most disabling medical condition among adolescents worldwide. Adolescent-onset bipolar disorder can often be a particularly severe variant of this illness, underscoring the need for early identification and treatment. Dr. Goldstein’s research focuses on biomarker validation and novel treatments. Psychological factors are central to Dr. Goldstein’s work. For example, Dr. Goldstein’s current studies examine neurocognition, fMRI, and the impact of psychological traits (e.g. impulsivity, lability) and environmental factors (e.g. family functioning, life events) on symptom course and treatment response. Dr. Goldstein is also interested in novel applications of evidence-based psychotherapies for adolescents with bipolar disorder and adolescent offspring of parents with bipolar disorder. Currently, he is the Director for the Centre for Youth Bipolar Disorder at CAMH.